Philip J. Mease, MD, and Alexis R. Ogdie-Beatty, MD, review the pathogenesis and a wide spectrum of clinical features, manifestations, and comorbidities of psoriatic arthritis; talk about classification criteria for PsA and different patient-reported and provider-assessed outcome measures; and discuss treatment recommendations and strategies, as well as various types of current and emerging therapies. Finally, they highlight some of the key issues and challenges of the management of PsA through reviewing patient case studies.
- Clinical features, manifestations, and comorbidities
- Classification criteria
- Outcomes measures
- GRAPPA/EULAR and ACR/NPF treatment recommendations
- Treat-to-target strategy
- Pharmacologic therapeutic classes
- PsA care (traditional model vs personalized medicine)
- Case studies
This activity was developed for rheumatologists, dermatologists, primary care physicians, nurse practitioners, physician assistants and other health care providers who manage patients with psoriatic arthritis (PsA).
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Penn Psoriatic Arthritis Clinic
University of Pennsylvania
Seattle Rheumatology Associates
Swedish Medical Center
University of Washington
2.50 AMA PRA Category 1 Credits™.
2.50 AANP Contact Hours
|Opens:||January 31, 2020|
|Expires:||January 30, 2021|
Primary Care Physicians
Other Healthcare Providers